Key Board Approvals

The Board of Directors approved the following items:

  • Standalone & Consolidated Un-Audited Financial Results for the Quarter and Half Year ended 30th September 2026
  • Limited Review Reports issued by Statutory Auditors on both Standalone and Consolidated unaudited financial results for the same period
  • Statement on Deviation or Variation of funds under Regulation 32 of SEBI LODR
  • Appointment of Ms. Bhagyshree Manojbhai Kandoi (Membership No. A82504) as Company Secretary and Compliance Officer effective 16th November 2026

Meeting Details

The Board meeting commenced at 4:00 PM and concluded at 5:15 PM on 13th November 2026.

Appointment Details

Ms. Bhagyshree Manojbhai Kandoi was appointed based on the recommendation of the Nomination and Remuneration Committee. She is an Associate Member of the Institute of Company Secretaries of India (ACS 82504) holding B.Com. and LL.B. degrees with experience in corporate secretarial, legal and regulatory compliances under Companies Act, 2013 and SEBI Regulations. Her expertise includes stock exchange filings, MCA compliances, Board and Committee matters, Annual Reports, dividend and IEPF compliances, secretarial audits, and drafting and vetting of legal documents. No relationships between directors were disclosed as the appointment was not for a director position.

Standalone Financial Performance (Rs. in Lakhs)

Quarter Ended 30 September 2026:

  • Revenue from Operations: ₹59.21
  • Total Income: ₹59.21
  • Total Expenses: ₹64.61
  • Loss before tax: ₹(5.40)
  • Loss after tax: ₹(5.40)
  • Total Comprehensive Income: ₹(5.40)
  • Basic EPS: ₹(0.05)
  • Diluted EPS: ₹(0.05)

Half Year Ended 30 September 2026:

  • Revenue from Operations: ₹126.06
  • Total Income: ₹126.06
  • Total Expenses: ₹143.51
  • Loss before tax: ₹(17.45)
  • Loss after tax: ₹(17.45)
  • Total Comprehensive Income: ₹(17.45)
  • Basic EPS: ₹(0.17)
  • Diluted EPS: ₹(0.17)

Comparative Figures (Previous Year):

  • Quarter Ended 30 September 2025: Revenue ₹19.62, Loss ₹(3.49)
  • Half Year Ended 30 September 2025: Revenue ₹19.62, Loss ₹(7.03)
  • Year Ended 31 March 2026: Revenue ₹126.54, Loss ₹(25.47)

Standalone Balance Sheet (As at 30 September 2026, Rs. in Lakhs)

  • Total Assets: ₹582.92 (vs. ₹118.89 as at 31 March 2026)
  • Investments: ₹462.78 (vs. ₹0)
  • Inventories: ₹4.16 (vs. ₹0)
  • Trade Receivables: ₹36.61 (vs. ₹59.65)
  • Cash & Cash Equivalents: ₹49.09 (vs. ₹1.53)
  • Equity Share Capital: ₹555.79 (vs. ₹301.40)
  • Other Equity: ₹(206.80) (vs. ₹(424.22))
  • Total Equity: ₹348.99 (vs. ₹(122.82))
  • Borrowings: ₹182.17 (vs. ₹147.27)
  • Trade Payables: ₹0.38 (vs. ₹39.44)

Standalone Cash Flow (Half Year Ended 30 September 2026, Rs. in Lakhs)

  • Net cash used in operating activities: ₹(13.82)
  • Net cash from financing activities: ₹61.39
  • Net increase in cash: ₹47.57
  • Cash at beginning: ₹1.53
  • Cash at end: ₹49.10

Consolidated Financial Performance (Rs. in Lakhs)

Quarter Ended 30 September 2026:

  • Revenue from Operations: ₹355.61
  • Other Income: ₹4.50
  • Total Income: ₹360.11
  • Total Expenses: ₹344.17
  • Profit before tax: ₹15.94
  • Tax expense: ₹6.64
  • Profit after tax: ₹9.30
  • Other Comprehensive Income: ₹19.42
  • Total Comprehensive Income: ₹28.72
  • Basic EPS: ₹0.09
  • Diluted EPS: ₹0.09

Half Year Ended 30 September 2026:

  • Revenue from Operations: ₹422.46
  • Other Income: ₹4.50
  • Total Income: ₹426.96
  • Total Expenses: ₹423.07
  • Profit before tax: ₹3.89
  • Tax expense: ₹6.64
  • Loss after tax: ₹(2.75)
  • Other Comprehensive Income: ₹19.42
  • Total Comprehensive Income: ₹16.67
  • Basic EPS: ₹(0.03)
  • Diluted EPS: ₹(0.03)

Consolidated Balance Sheet (As at 30 September 2026, Rs. in Lakhs)

  • Total Assets: ₹2,808.30 (vs. ₹118.89 as at 31 March 2026)
  • Property, Plant & Equipment: ₹821.70
  • Investments: ₹241.69
  • Inventories: ₹346.52
  • Trade Receivables: ₹577.82
  • Cash & Cash Equivalents: ₹52.04
  • Equity Share Capital: ₹555.79 (vs. ₹301.40)
  • Other Equity: ₹(172.68) (vs. ₹(424.22))
  • Total Equity: ₹383.11 (vs. ₹(122.82))
  • Borrowings: ₹1,993.71 (Non-current ₹1,457.34 + Current ₹536.37)

Consolidated Cash Flow (Half Year Ended 30 September 2026, Rs. in Lakhs)

  • Net cash used in operating activities: ₹(103.41)
  • Net cash used in investing activities: ₹(171.98)
  • Net cash from financing activities: ₹322.44
  • Net increase in cash: ₹47.05
  • Cash at beginning: ₹1.53
  • Cash at end: ₹52.04

Auditor's Review

M/s Y M Shah & Co., Chartered Accountants (FRN: 114124W) issued unmodified limited review reports for both standalone and consolidated financial results. The reviews were conducted in accordance with Standard on Review Engagements (SRE) 2410 issued by ICAI. The auditors concluded that nothing came to their attention that causes them to believe that the financial results were not prepared in accordance with recognition and measurement principles of Indian Accounting Standards.

Subsidiary Information

The consolidated results include Radiant Parenterals Limited as a subsidiary. The subsidiary's financial results were reviewed by other auditors, and the main auditor's conclusion is based on those reports.

Accounting Policies

The financial results were prepared in accordance with Indian Accounting Standard (Ind AS) 34 - Interim Financial Reporting, prescribed under Section 133 of the Companies Act, 2013, and Regulation 33 of SEBI (LODR) Regulations, 2015. The company operates in a single business segment, making segment reporting under Ind-AS 108 not applicable. EPS was computed in accordance with Ind AS 33.